Back
Zevra Therapeutics, Inc. Stock Price Chart
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
39
ZVRA
Zevra Therapeutics, Inc.
Last Price:
$8.65
Seasonality Move:
-2.32%
7 Day Trial
ALL ACCESS PASS
$
7
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZVRA is experiencing slight buying pressure.
Zevra Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.5 | Buy |
| 20-day SMA: | 8.91 | Sell |
| 50-day SMA: | 9.81 | Sell |
| 200-day SMA: | 9.09 | Sell |
| 8-day EMA: | 8.47 | Buy |
| 20-day EMA: | 7.14 | Buy |
| 50-day EMA: | 4.35 | Buy |
| 200-day EMA: | 1.39 | Buy |
Zevra Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.75 | Buy |
| Relative Strength Index (14 RSI): | 43.51 | Sell |
| Chaikin Money Flow: | 114269 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.53 - 9.75) | Sell |
| Bollinger Bands (100): | (8.52 - 11.1) | Sell |
Zevra Therapeutics, Inc. Technical Analysis
| Nov 20 | Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 20 | 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Zevra Therapeutics, Inc. Stock
Is Zevra Therapeutics, Inc. Stock a Buy?
-
Zevra Therapeutics, Inc. share price is 8.66 while ZVRA 8-day simple moving average is 8.50, which is a Buy signal.
-
The stock price of ZVRA is 8.66 while Zevra Therapeutics, Inc. 20-day SMA is 8.91, which makes it a Sell.
-
Zevra Therapeutics, Inc. 50-day simple moving average is 9.81 while ZVRA share price is 8.66, making it a Sell technically.
-
ZVRA stock price is 8.66 and Zevra Therapeutics, Inc. 200-day simple moving average is 9.09, creating a Sell signal.
ZVRA Technical Analysis vs Fundamental Analysis
Sell
39
Zevra Therapeutics, Inc. (ZVRA)
is a Sell
Is Zevra Therapeutics, Inc. a Buy or a Sell?
-
Zevra Therapeutics, Inc. stock is rated a SellThe current Zevra Therapeutics, Inc. [ZVRA] share price is $8.66. The Score for ZVRA is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
Zevra Therapeutics, Inc. Stock Info
Market Cap:
487.5M
Price in USD:
8.66
Share Volume:
825.3K
Zevra Therapeutics, Inc. 52-Week Range
52-Week High:
13.16
52-Week Low:
6.19
Sell
39
Zevra Therapeutics, Inc. (ZVRA)
is a Sell
Zevra Therapeutics, Inc. Share Price Forecast
-
What is the Zevra Therapeutics, Inc. stock price today?The Zevra Therapeutics, Inc. stock price is 8.66 USD today.
-
Will ZVRA stock go up or go down?Zevra Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Zevra Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Zevra Therapeutics, Inc. is overvalued.
Is Zevra Therapeutics, Inc. Stock a Buy?
-
Zevra Therapeutics, Inc. share price is 8.66 while ZVRA 8-day exponential moving average is 8.47, which is a Buy signal.
-
The stock price of ZVRA is 8.66 while Zevra Therapeutics, Inc. 20-day EMA is 7.14, which makes it a Buy.
-
Zevra Therapeutics, Inc. 50-day exponential moving average is 4.35 while ZVRA share price is 8.66, making it a Buy technically.
-
ZVRA stock price is 8.66 and Zevra Therapeutics, Inc. 200-day simple moving average is 1.39, creating a Buy signal.
Fundamental Analysis of Zevra Therapeutics, Inc.
Is Zevra Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.09 per share, and a decrease next year of $0.54 per share.
Technical Analysis of Zevra Therapeutics, Inc.
Should I short Zevra Therapeutics, Inc. stock?
-
ZVRA Moving Average Covergence Divergence (MACD) indicator is 1.75, suggesting Zevra Therapeutics, Inc. is a Buy
-
Zevra Therapeutics, Inc. Relative Strength Index (RSI) is 43.51, which suggest Zevra Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Zevra Therapeutics, Inc. is (8.53 - 9.75), which suggest Zevra Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Zevra Therapeutics, Inc. is (8.52 - 11.1), which suggest Zevra Therapeutics, Inc. is a Sell
* Zevra Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.